S&P 500   3,360.42 (+0.27%)
DOW   27,780.92 (+1.27%)
QQQ   269.94 (-0.56%)
AAPL   452.53 (+1.82%)
MSFT   207.33 (-2.42%)
FB   263.59 (-1.81%)
GOOGL   1,495.58 (-0.19%)
AMZN   3,148.91 (-0.59%)
NVDA   449.51 (+0.34%)
CGC   18.09 (+8.78%)
BABA   248.02 (-1.62%)
TSLA   1,422.76 (-2.06%)
MU   49.39 (+1.31%)
GE   6.65 (+3.91%)
AMD   82.66 (-2.58%)
T   30.16 (+0.47%)
F   7.07 (+3.06%)
ACB   10.26 (-0.10%)
GILD   68.43 (-1.33%)
NFLX   486.29 (-1.71%)
DIS   128.90 (-0.79%)
BAC   26.54 (+1.65%)
BA   178.28 (+4.86%)
S&P 500   3,360.42 (+0.27%)
DOW   27,780.92 (+1.27%)
QQQ   269.94 (-0.56%)
AAPL   452.53 (+1.82%)
MSFT   207.33 (-2.42%)
FB   263.59 (-1.81%)
GOOGL   1,495.58 (-0.19%)
AMZN   3,148.91 (-0.59%)
NVDA   449.51 (+0.34%)
CGC   18.09 (+8.78%)
BABA   248.02 (-1.62%)
TSLA   1,422.76 (-2.06%)
MU   49.39 (+1.31%)
GE   6.65 (+3.91%)
AMD   82.66 (-2.58%)
T   30.16 (+0.47%)
F   7.07 (+3.06%)
ACB   10.26 (-0.10%)
GILD   68.43 (-1.33%)
NFLX   486.29 (-1.71%)
DIS   128.90 (-0.79%)
BAC   26.54 (+1.65%)
BA   178.28 (+4.86%)
S&P 500   3,360.42 (+0.27%)
DOW   27,780.92 (+1.27%)
QQQ   269.94 (-0.56%)
AAPL   452.53 (+1.82%)
MSFT   207.33 (-2.42%)
FB   263.59 (-1.81%)
GOOGL   1,495.58 (-0.19%)
AMZN   3,148.91 (-0.59%)
NVDA   449.51 (+0.34%)
CGC   18.09 (+8.78%)
BABA   248.02 (-1.62%)
TSLA   1,422.76 (-2.06%)
MU   49.39 (+1.31%)
GE   6.65 (+3.91%)
AMD   82.66 (-2.58%)
T   30.16 (+0.47%)
F   7.07 (+3.06%)
ACB   10.26 (-0.10%)
GILD   68.43 (-1.33%)
NFLX   486.29 (-1.71%)
DIS   128.90 (-0.79%)
BAC   26.54 (+1.65%)
BA   178.28 (+4.86%)
S&P 500   3,360.42 (+0.27%)
DOW   27,780.92 (+1.27%)
QQQ   269.94 (-0.56%)
AAPL   452.53 (+1.82%)
MSFT   207.33 (-2.42%)
FB   263.59 (-1.81%)
GOOGL   1,495.58 (-0.19%)
AMZN   3,148.91 (-0.59%)
NVDA   449.51 (+0.34%)
CGC   18.09 (+8.78%)
BABA   248.02 (-1.62%)
TSLA   1,422.76 (-2.06%)
MU   49.39 (+1.31%)
GE   6.65 (+3.91%)
AMD   82.66 (-2.58%)
T   30.16 (+0.47%)
F   7.07 (+3.06%)
ACB   10.26 (-0.10%)
GILD   68.43 (-1.33%)
NFLX   486.29 (-1.71%)
DIS   128.90 (-0.79%)
BAC   26.54 (+1.65%)
BA   178.28 (+4.86%)
Log in

NASDAQ:GOSSGossamer Bio Price Target & Analyst Ratings

$13.64
+0.08 (+0.59 %)
(As of 08/10/2020 03:04 PM ET)
Add
Compare
Today's Range
$13.57
Now: $13.64
$14.04
50-Day Range
$11.92
MA: $13.07
$14.75
52-Week Range
$7.52
Now: $13.64
$27.15
Volume8,880 shs
Average Volume612,777 shs
Market Capitalization$905.15 million
P/E RatioN/A
Dividend YieldN/A
Beta1.06

Analyst Ratings

Gossamer Bio (NASDAQ:GOSS) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
8 Wall Street analysts have issued ratings and price targets for Gossamer Bio in the last 12 months. Their average twelve-month price target is $30.50, suggesting that the stock has a possible upside of 123.61%. The high price target for GOSS is $36.00 and the low price target for GOSS is $21.00. There are currently 8 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $30.50$29.50$28.17$29.17
Price Target Upside: 123.61% upside136.19% upside139.31% upside82.75% upside

Gossamer Bio (NASDAQ:GOSS) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Gossamer Bio (NASDAQ:GOSS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/14/2020Cantor FitzgeraldBoost Price TargetOverweight$25.00 ➝ $33.00High
6/29/2020HC WainwrightInitiated CoverageBuy$31.00High
5/20/2020SVB LeerinkBoost Price TargetPositive ➝ Outperform$27.00 ➝ $36.00Low
4/22/2020Piper SandlerInitiated CoverageOverweight$30.00High
2/27/2020BarclaysInitiated CoverageOverweight$21.00High
12/3/2019Bank of AmericaInitiated CoverageBuy$32.00Low
10/30/2019Berenberg BankInitiated CoverageBuy$31.00High
8/12/2019Evercore ISISet Price TargetBuy$30.00Medium
(Data available from 8/10/2018 forward)
This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.